List of Excipients in API octreotide
✉ Email this page to a colleague
Excipients in NDA-approved (novel) drugs containing octreotide
Company | Tradename | Ingredient | NDC | Excipient | Potential Generic Entry |
---|---|---|---|---|---|
Chiesi USA Inc | MYCAPSSA | octreotide | 10122-550 | AMMONIA | |
Chiesi USA Inc | MYCAPSSA | octreotide | 10122-550 | FERROSOFERRIC OXIDE | |
Chiesi USA Inc | MYCAPSSA | octreotide | 10122-550 | GELATIN | |
>Company | >Tradename | >Ingredient | >NDC | >Excipient | >Potential Generic Entry |
Excipients in ANDA-approved (generic) drugs containing octreotide
Company | Ingredient | NDC | Excipient |
---|---|---|---|
Hikma Pharmaceuticals USA Inc | octreotide acetate | 0641-6174 | LACTIC ACID, L- |
Hikma Pharmaceuticals USA Inc | octreotide acetate | 0641-6174 | SODIUM CHLORIDE |
Hikma Pharmaceuticals USA Inc | octreotide acetate | 0641-6174 | SODIUM HYDROXIDE |
>Company | >Ingredient | >NDC | >Excipient |
Detailed excipient profiles for octreotide
Excipient focus: ACETIC ACID
octreotide drug variants containing ACETIC ACID
Company | Ingredient | NDC |
---|---|---|
Teva Parenteral Medicines Inc | octreotide acetate | 0703-3301 |
Heritage Pharmaceuticals Inc d/b/a Avet Pharmaceuticals Inc | octreotide acetate | 23155-685 |
Sagent Pharmaceuticals | octreotide acetate | 25021-451 |
>Company | >Ingredient | >NDC |
octreotide drug variants not containing ACETIC ACID
Company | Ingredient | NDC |
---|---|---|
Chiesi USA Inc | octreotide | 10122-550 |
Amryt Pharmaceuticals Designated Activity Company | octreotide | 69880-120 |
Novartis Pharmaceuticals Corporation | octreotide acetate | 0078-0180 |
>Company | >Ingredient | >NDC |
Excipient focus: AMMONIA
octreotide drug variants containing AMMONIA
Company | Ingredient | NDC |
---|---|---|
Chiesi USA Inc | octreotide | 10122-550 |
Amryt Pharmaceuticals Designated Activity Company | octreotide | 69880-120 |
>Company | >Ingredient | >NDC |
octreotide drug variants not containing AMMONIA
Company | Ingredient | NDC |
---|---|---|
Novartis Pharmaceuticals Corporation | octreotide acetate | 0078-0180 |
Hikma Pharmaceuticals USA Inc | octreotide acetate | 0641-6174 |
Teva Parenteral Medicines Inc | octreotide acetate | 0703-3301 |
>Company | >Ingredient | >NDC |
Excipient focus: FERROSOFERRIC OXIDE
octreotide drug variants containing FERROSOFERRIC OXIDE
Company | Ingredient | NDC |
---|---|---|
Chiesi USA Inc | octreotide | 10122-550 |
Amryt Pharmaceuticals Designated Activity Company | octreotide | 69880-120 |
>Company | >Ingredient | >NDC |
octreotide drug variants not containing FERROSOFERRIC OXIDE
Company | Ingredient | NDC |
---|---|---|
Novartis Pharmaceuticals Corporation | octreotide acetate | 0078-0180 |
Hikma Pharmaceuticals USA Inc | octreotide acetate | 0641-6174 |
Teva Parenteral Medicines Inc | octreotide acetate | 0703-3301 |
>Company | >Ingredient | >NDC |
Excipient focus: GELATIN
octreotide drug variants containing GELATIN
Company | Ingredient | NDC |
---|---|---|
Chiesi USA Inc | octreotide | 10122-550 |
Amryt Pharmaceuticals Designated Activity Company | octreotide | 69880-120 |
>Company | >Ingredient | >NDC |
octreotide drug variants not containing GELATIN
Company | Ingredient | NDC |
---|---|---|
Novartis Pharmaceuticals Corporation | octreotide acetate | 0078-0180 |
Hikma Pharmaceuticals USA Inc | octreotide acetate | 0641-6174 |
Teva Parenteral Medicines Inc | octreotide acetate | 0703-3301 |
>Company | >Ingredient | >NDC |
Excipient focus: GLYCERYL MONOCAPRYLATE
octreotide drug variants containing GLYCERYL MONOCAPRYLATE
Company | Ingredient | NDC |
---|---|---|
Chiesi USA Inc | octreotide | 10122-550 |
Amryt Pharmaceuticals Designated Activity Company | octreotide | 69880-120 |
>Company | >Ingredient | >NDC |
octreotide drug variants not containing GLYCERYL MONOCAPRYLATE
Company | Ingredient | NDC |
---|---|---|
Novartis Pharmaceuticals Corporation | octreotide acetate | 0078-0180 |
Hikma Pharmaceuticals USA Inc | octreotide acetate | 0641-6174 |
Teva Parenteral Medicines Inc | octreotide acetate | 0703-3301 |
>Company | >Ingredient | >NDC |
Excipient focus: LACTIC ACID
octreotide drug variants containing LACTIC ACID
Company | Ingredient | NDC |
---|---|---|
Novartis Pharmaceuticals Corporation | octreotide acetate | 0078-0180 |
Sun Pharmaceutical Industries Inc | octreotide acetate | 62756-452 |
Gland Pharma Limited | octreotide acetate | 68083-515 |
>Company | >Ingredient | >NDC |
octreotide drug variants not containing LACTIC ACID
Company | Ingredient | NDC |
---|---|---|
Chiesi USA Inc | octreotide | 10122-550 |
Amryt Pharmaceuticals Designated Activity Company | octreotide | 69880-120 |
Hikma Pharmaceuticals USA Inc | octreotide acetate | 0641-6174 |
>Company | >Ingredient | >NDC |
Excipient focus: LACTIC ACID, L-
octreotide drug variants containing LACTIC ACID, L-
Company | Ingredient | NDC |
---|---|---|
Hikma Pharmaceuticals USA Inc | octreotide acetate | 0641-6174 |
Mylan Institutional LLC | octreotide acetate | 67457-239 |
>Company | >Ingredient | >NDC |
octreotide drug variants not containing LACTIC ACID, L-
Company | Ingredient | NDC |
---|---|---|
Chiesi USA Inc | octreotide | 10122-550 |
Amryt Pharmaceuticals Designated Activity Company | octreotide | 69880-120 |
Novartis Pharmaceuticals Corporation | octreotide acetate | 0078-0180 |
>Company | >Ingredient | >NDC |
Excipient focus: MAGNESIUM CHLORIDE
octreotide drug variants containing MAGNESIUM CHLORIDE
Company | Ingredient | NDC |
---|---|---|
Chiesi USA Inc | octreotide | 10122-550 |
Amryt Pharmaceuticals Designated Activity Company | octreotide | 69880-120 |
>Company | >Ingredient | >NDC |
octreotide drug variants not containing MAGNESIUM CHLORIDE
Company | Ingredient | NDC |
---|---|---|
Novartis Pharmaceuticals Corporation | octreotide acetate | 0078-0180 |
Hikma Pharmaceuticals USA Inc | octreotide acetate | 0641-6174 |
Teva Parenteral Medicines Inc | octreotide acetate | 0703-3301 |
>Company | >Ingredient | >NDC |
Excipient focus: MANNITOL
octreotide drug variants containing MANNITOL
Company | Ingredient | NDC |
---|---|---|
Novartis Pharmaceuticals Corporation | octreotide acetate | 0078-0180 |
Teva Parenteral Medicines Inc | octreotide acetate | 0703-3301 |
Sun Pharmaceutical Industries Inc | octreotide acetate | 62756-452 |
>Company | >Ingredient | >NDC |
octreotide drug variants not containing MANNITOL
Company | Ingredient | NDC |
---|---|---|
Chiesi USA Inc | octreotide | 10122-550 |
Amryt Pharmaceuticals Designated Activity Company | octreotide | 69880-120 |
Hikma Pharmaceuticals USA Inc | octreotide acetate | 0641-6174 |
>Company | >Ingredient | >NDC |
Excipient focus: METHACRYLIC ACID AND ETHYL ACRYLATE COPOLYMER
octreotide drug variants containing METHACRYLIC ACID AND ETHYL ACRYLATE COPOLYMER
Company | Ingredient | NDC |
---|---|---|
Chiesi USA Inc | octreotide | 10122-550 |
Amryt Pharmaceuticals Designated Activity Company | octreotide | 69880-120 |
>Company | >Ingredient | >NDC |
octreotide drug variants not containing METHACRYLIC ACID AND ETHYL ACRYLATE COPOLYMER
Company | Ingredient | NDC |
---|---|---|
Novartis Pharmaceuticals Corporation | octreotide acetate | 0078-0180 |
Hikma Pharmaceuticals USA Inc | octreotide acetate | 0641-6174 |
Teva Parenteral Medicines Inc | octreotide acetate | 0703-3301 |
>Company | >Ingredient | >NDC |
Excipient focus: PHENOL
octreotide drug variants containing PHENOL
Company | Ingredient | NDC |
---|---|---|
Heritage Pharmaceuticals Inc d/b/a Avet Pharmaceuticals Inc | octreotide acetate | 23155-685 |
Sun Pharmaceutical Industries Inc | octreotide acetate | 62756-452 |
Gland Pharma Limited | octreotide acetate | 68083-515 |
>Company | >Ingredient | >NDC |
octreotide drug variants not containing PHENOL
Company | Ingredient | NDC |
---|---|---|
Chiesi USA Inc | octreotide | 10122-550 |
Amryt Pharmaceuticals Designated Activity Company | octreotide | 69880-120 |
Novartis Pharmaceuticals Corporation | octreotide acetate | 0078-0180 |
>Company | >Ingredient | >NDC |
Excipient focus: POLYSORBATE 80
octreotide drug variants containing POLYSORBATE 80
Company | Ingredient | NDC |
---|---|---|
Chiesi USA Inc | octreotide | 10122-550 |
Amryt Pharmaceuticals Designated Activity Company | octreotide | 69880-120 |
>Company | >Ingredient | >NDC |
octreotide drug variants not containing POLYSORBATE 80
Company | Ingredient | NDC |
---|---|---|
Novartis Pharmaceuticals Corporation | octreotide acetate | 0078-0180 |
Hikma Pharmaceuticals USA Inc | octreotide acetate | 0641-6174 |
Teva Parenteral Medicines Inc | octreotide acetate | 0703-3301 |
>Company | >Ingredient | >NDC |
Excipient focus: POVIDONE K12
octreotide drug variants containing POVIDONE K12
Company | Ingredient | NDC |
---|---|---|
Chiesi USA Inc | octreotide | 10122-550 |
Amryt Pharmaceuticals Designated Activity Company | octreotide | 69880-120 |
>Company | >Ingredient | >NDC |
octreotide drug variants not containing POVIDONE K12
Company | Ingredient | NDC |
---|---|---|
Novartis Pharmaceuticals Corporation | octreotide acetate | 0078-0180 |
Hikma Pharmaceuticals USA Inc | octreotide acetate | 0641-6174 |
Teva Parenteral Medicines Inc | octreotide acetate | 0703-3301 |
>Company | >Ingredient | >NDC |
Excipient focus: PROPYLENE GLYCOL
octreotide drug variants containing PROPYLENE GLYCOL
Company | Ingredient | NDC |
---|---|---|
Chiesi USA Inc | octreotide | 10122-550 |
Amryt Pharmaceuticals Designated Activity Company | octreotide | 69880-120 |
>Company | >Ingredient | >NDC |
octreotide drug variants not containing PROPYLENE GLYCOL
Company | Ingredient | NDC |
---|---|---|
Novartis Pharmaceuticals Corporation | octreotide acetate | 0078-0180 |
Hikma Pharmaceuticals USA Inc | octreotide acetate | 0641-6174 |
Teva Parenteral Medicines Inc | octreotide acetate | 0703-3301 |
>Company | >Ingredient | >NDC |
Excipient focus: SHELLAC
octreotide drug variants containing SHELLAC
Company | Ingredient | NDC |
---|---|---|
Chiesi USA Inc | octreotide | 10122-550 |
Amryt Pharmaceuticals Designated Activity Company | octreotide | 69880-120 |
>Company | >Ingredient | >NDC |
octreotide drug variants not containing SHELLAC
Company | Ingredient | NDC |
---|---|---|
Novartis Pharmaceuticals Corporation | octreotide acetate | 0078-0180 |
Hikma Pharmaceuticals USA Inc | octreotide acetate | 0641-6174 |
Teva Parenteral Medicines Inc | octreotide acetate | 0703-3301 |
>Company | >Ingredient | >NDC |
Excipient focus: SILICON DIOXIDE
octreotide drug variants containing SILICON DIOXIDE
Company | Ingredient | NDC |
---|---|---|
Chiesi USA Inc | octreotide | 10122-550 |
Amryt Pharmaceuticals Designated Activity Company | octreotide | 69880-120 |
>Company | >Ingredient | >NDC |
octreotide drug variants not containing SILICON DIOXIDE
Company | Ingredient | NDC |
---|---|---|
Novartis Pharmaceuticals Corporation | octreotide acetate | 0078-0180 |
Hikma Pharmaceuticals USA Inc | octreotide acetate | 0641-6174 |
Teva Parenteral Medicines Inc | octreotide acetate | 0703-3301 |
>Company | >Ingredient | >NDC |
Excipient focus: SODIUM ACETATE
octreotide drug variants containing SODIUM ACETATE
Company | Ingredient | NDC |
---|---|---|
Teva Parenteral Medicines Inc | octreotide acetate | 0703-3301 |
Heritage Pharmaceuticals Inc d/b/a Avet Pharmaceuticals Inc | octreotide acetate | 23155-685 |
Sagent Pharmaceuticals | octreotide acetate | 25021-451 |
>Company | >Ingredient | >NDC |
octreotide drug variants not containing SODIUM ACETATE
Company | Ingredient | NDC |
---|---|---|
Chiesi USA Inc | octreotide | 10122-550 |
Amryt Pharmaceuticals Designated Activity Company | octreotide | 69880-120 |
Novartis Pharmaceuticals Corporation | octreotide acetate | 0078-0180 |
>Company | >Ingredient | >NDC |
Excipient focus: SODIUM BICARBONATE
octreotide drug variants containing SODIUM BICARBONATE
Company | Ingredient | NDC |
---|---|---|
Chiesi USA Inc | octreotide | 10122-550 |
Amryt Pharmaceuticals Designated Activity Company | octreotide | 69880-120 |
Novartis Pharmaceuticals Corporation | octreotide acetate | 0078-0180 |
>Company | >Ingredient | >NDC |
octreotide drug variants not containing SODIUM BICARBONATE
Company | Ingredient | NDC |
---|---|---|
Hikma Pharmaceuticals USA Inc | octreotide acetate | 0641-6174 |
Teva Parenteral Medicines Inc | octreotide acetate | 0703-3301 |
Heritage Pharmaceuticals Inc d/b/a Avet Pharmaceuticals Inc | octreotide acetate | 23155-685 |
>Company | >Ingredient | >NDC |
Excipient focus: SODIUM CAPRYLATE
octreotide drug variants containing SODIUM CAPRYLATE
Company | Ingredient | NDC |
---|---|---|
Chiesi USA Inc | octreotide | 10122-550 |
Amryt Pharmaceuticals Designated Activity Company | octreotide | 69880-120 |
>Company | >Ingredient | >NDC |
octreotide drug variants not containing SODIUM CAPRYLATE
Company | Ingredient | NDC |
---|---|---|
Novartis Pharmaceuticals Corporation | octreotide acetate | 0078-0180 |
Hikma Pharmaceuticals USA Inc | octreotide acetate | 0641-6174 |
Teva Parenteral Medicines Inc | octreotide acetate | 0703-3301 |
>Company | >Ingredient | >NDC |
Excipient focus: SODIUM CHLORIDE
octreotide drug variants containing SODIUM CHLORIDE
Company | Ingredient | NDC |
---|---|---|
Hikma Pharmaceuticals USA Inc | octreotide acetate | 0641-6174 |
Heritage Pharmaceuticals Inc d/b/a Avet Pharmaceuticals Inc | octreotide acetate | 23155-685 |
Sagent Pharmaceuticals | octreotide acetate | 25021-451 |
>Company | >Ingredient | >NDC |
octreotide drug variants not containing SODIUM CHLORIDE
Company | Ingredient | NDC |
---|---|---|
Chiesi USA Inc | octreotide | 10122-550 |
Amryt Pharmaceuticals Designated Activity Company | octreotide | 69880-120 |
Novartis Pharmaceuticals Corporation | octreotide acetate | 0078-0180 |
>Company | >Ingredient | >NDC |
Excipient focus: SODIUM HYDROXIDE
octreotide drug variants containing SODIUM HYDROXIDE
Company | Ingredient | NDC |
---|---|---|
Hikma Pharmaceuticals USA Inc | octreotide acetate | 0641-6174 |
Mylan Institutional LLC | octreotide acetate | 67457-239 |
>Company | >Ingredient | >NDC |
octreotide drug variants not containing SODIUM HYDROXIDE
Company | Ingredient | NDC |
---|---|---|
Chiesi USA Inc | octreotide | 10122-550 |
Amryt Pharmaceuticals Designated Activity Company | octreotide | 69880-120 |
Novartis Pharmaceuticals Corporation | octreotide acetate | 0078-0180 |
>Company | >Ingredient | >NDC |
Excipient focus: SODIUM LAURYL SULFATE
octreotide drug variants containing SODIUM LAURYL SULFATE
Company | Ingredient | NDC |
---|---|---|
Chiesi USA Inc | octreotide | 10122-550 |
Amryt Pharmaceuticals Designated Activity Company | octreotide | 69880-120 |
>Company | >Ingredient | >NDC |
octreotide drug variants not containing SODIUM LAURYL SULFATE
Company | Ingredient | NDC |
---|---|---|
Novartis Pharmaceuticals Corporation | octreotide acetate | 0078-0180 |
Hikma Pharmaceuticals USA Inc | octreotide acetate | 0641-6174 |
Teva Parenteral Medicines Inc | octreotide acetate | 0703-3301 |
>Company | >Ingredient | >NDC |
Excipient focus: TALC
octreotide drug variants containing TALC
Company | Ingredient | NDC |
---|---|---|
Chiesi USA Inc | octreotide | 10122-550 |
Amryt Pharmaceuticals Designated Activity Company | octreotide | 69880-120 |
>Company | >Ingredient | >NDC |
octreotide drug variants not containing TALC
Company | Ingredient | NDC |
---|---|---|
Novartis Pharmaceuticals Corporation | octreotide acetate | 0078-0180 |
Hikma Pharmaceuticals USA Inc | octreotide acetate | 0641-6174 |
Teva Parenteral Medicines Inc | octreotide acetate | 0703-3301 |
>Company | >Ingredient | >NDC |
Excipient focus: TITANIUM DIOXIDE
octreotide drug variants containing TITANIUM DIOXIDE
Company | Ingredient | NDC |
---|---|---|
Chiesi USA Inc | octreotide | 10122-550 |
Amryt Pharmaceuticals Designated Activity Company | octreotide | 69880-120 |
>Company | >Ingredient | >NDC |
octreotide drug variants not containing TITANIUM DIOXIDE
Company | Ingredient | NDC |
---|---|---|
Novartis Pharmaceuticals Corporation | octreotide acetate | 0078-0180 |
Hikma Pharmaceuticals USA Inc | octreotide acetate | 0641-6174 |
Teva Parenteral Medicines Inc | octreotide acetate | 0703-3301 |
>Company | >Ingredient | >NDC |
Excipient focus: TRICAPRILIN
octreotide drug variants containing TRICAPRILIN
Company | Ingredient | NDC |
---|---|---|
Chiesi USA Inc | octreotide | 10122-550 |
Amryt Pharmaceuticals Designated Activity Company | octreotide | 69880-120 |
>Company | >Ingredient | >NDC |
octreotide drug variants not containing TRICAPRILIN
Company | Ingredient | NDC |
---|---|---|
Novartis Pharmaceuticals Corporation | octreotide acetate | 0078-0180 |
Hikma Pharmaceuticals USA Inc | octreotide acetate | 0641-6174 |
Teva Parenteral Medicines Inc | octreotide acetate | 0703-3301 |
>Company | >Ingredient | >NDC |
Excipient focus: TRIETHYL CITRATE
octreotide drug variants containing TRIETHYL CITRATE
Company | Ingredient | NDC |
---|---|---|
Chiesi USA Inc | octreotide | 10122-550 |
Amryt Pharmaceuticals Designated Activity Company | octreotide | 69880-120 |
>Company | >Ingredient | >NDC |
octreotide drug variants not containing TRIETHYL CITRATE
Company | Ingredient | NDC |
---|---|---|
Novartis Pharmaceuticals Corporation | octreotide acetate | 0078-0180 |
Hikma Pharmaceuticals USA Inc | octreotide acetate | 0641-6174 |
Teva Parenteral Medicines Inc | octreotide acetate | 0703-3301 |
>Company | >Ingredient | >NDC |
Excipient focus: WATER
octreotide drug variants containing WATER
Company | Ingredient | NDC |
---|---|---|
Novartis Pharmaceuticals Corporation | octreotide acetate | 0078-0180 |
Hikma Pharmaceuticals USA Inc | octreotide acetate | 0641-6174 |
Teva Parenteral Medicines Inc | octreotide acetate | 0703-3301 |
>Company | >Ingredient | >NDC |
octreotide drug variants not containing WATER
Company | Ingredient | NDC |
---|---|---|
Chiesi USA Inc | octreotide | 10122-550 |
Amryt Pharmaceuticals Designated Activity Company | octreotide | 69880-120 |
Fresenius Kabi USA LLC | octreotide acetate | 63323-365 |
>Company | >Ingredient | >NDC |
Make Better Decisions: Try a trial or see plans & pricing
Drugs may be covered by multiple patents or regulatory protections. All trademarks and applicant names are the property of their respective owners or licensors. Although great care is taken in the proper and correct provision of this service, thinkBiotech LLC does not accept any responsibility for possible consequences of errors or omissions in the provided data. The data presented herein is for information purposes only. There is no warranty that the data contained herein is error free. thinkBiotech performs no independent verification of facts as provided by public sources nor are attempts made to provide legal or investing advice. Any reliance on data provided herein is done solely at the discretion of the user. Users of this service are advised to seek professional advice and independent confirmation before considering acting on any of the provided information. thinkBiotech LLC reserves the right to amend, extend or withdraw any part or all of the offered service without notice.